Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N.
Isoniazid represents a first-line anti-tuberculosis medication in prevention and treatment. This prodrug is activated by a mycobacterial catalase-peroxidase enzyme called KatG in Mycobacterium tuberculosis), thereby inhibiting the synthesis of mycolic acid, required for the mycobacterial cell wall....
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d912f31bc02142dcb6a8c54aacb115a9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d912f31bc02142dcb6a8c54aacb115a9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d912f31bc02142dcb6a8c54aacb115a92021-11-18T09:01:44ZIsoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N.1932-620310.1371/journal.pone.0069762https://doaj.org/article/d912f31bc02142dcb6a8c54aacb115a92013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23936350/?tool=EBIhttps://doaj.org/toc/1932-6203Isoniazid represents a first-line anti-tuberculosis medication in prevention and treatment. This prodrug is activated by a mycobacterial catalase-peroxidase enzyme called KatG in Mycobacterium tuberculosis), thereby inhibiting the synthesis of mycolic acid, required for the mycobacterial cell wall. Moreover, isoniazid activation by KatG produces some radical species (e.g., nitrogen monoxide), that display anti-mycobacterial activity. Remarkably, the ability of mycobacteria to persist in vivo in the presence of reactive nitrogen and oxygen species implies the presence in these bacteria of (pseudo-)enzymatic detoxification systems, including truncated hemoglobins (trHbs). Here, we report that isoniazid binds reversibly to ferric and ferrous M. tuberculosis trHb type N (or group I; Mt-trHbN(III) and Mt-trHbN(II), respectively) with a simple bimolecular process, which perturbs the heme-based spectroscopic properties. Values of thermodynamic and kinetic parameters for isoniazid binding to Mt-trHbN(III) and Mt-trHbN(II) are K= (1.1 ± 0.1)× 10(-4) M, k on= (5.3 ± 0.6)× 10(3) M(-1) s(-1) and k off= (4.6 ± 0.5)× 10(-1) s(-1); and D= (1.2 ± 0.2)× 10(-3) M, d on= (1.3 ± 0.4)× 10(3) M(-1) s(-1), and d off=1.5 ± 0.4 s(-1), respectively, at pH 7.0 and 20.0°C. Accordingly, isoniazid inhibits competitively azide binding to Mt-trHbN(III) and Mt-trHbN(III)-catalyzed peroxynitrite isomerization. Moreover, isoniazid inhibits Mt-trHbN(II) oxygenation and carbonylation. Although the structure of the Mt-trHbN-isoniazid complex is not available, here we show by docking simulation that isoniazid binding to the heme-Fe atom indeed may take place. These data suggest a direct role of isoniazid to impair fundamental functions of mycobacteria, e.g. scavenging of reactive nitrogen and oxygen species, and metabolism.Paolo AscenziAndrea ColettaYu CaoViviana TrezzaLoris LeboffeGabriella FanaliMauro FasanoAlessandra PesceChiara CiaccioStefano MariniMassimo ColettaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e69762 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Paolo Ascenzi Andrea Coletta Yu Cao Viviana Trezza Loris Leboffe Gabriella Fanali Mauro Fasano Alessandra Pesce Chiara Ciaccio Stefano Marini Massimo Coletta Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| description |
Isoniazid represents a first-line anti-tuberculosis medication in prevention and treatment. This prodrug is activated by a mycobacterial catalase-peroxidase enzyme called KatG in Mycobacterium tuberculosis), thereby inhibiting the synthesis of mycolic acid, required for the mycobacterial cell wall. Moreover, isoniazid activation by KatG produces some radical species (e.g., nitrogen monoxide), that display anti-mycobacterial activity. Remarkably, the ability of mycobacteria to persist in vivo in the presence of reactive nitrogen and oxygen species implies the presence in these bacteria of (pseudo-)enzymatic detoxification systems, including truncated hemoglobins (trHbs). Here, we report that isoniazid binds reversibly to ferric and ferrous M. tuberculosis trHb type N (or group I; Mt-trHbN(III) and Mt-trHbN(II), respectively) with a simple bimolecular process, which perturbs the heme-based spectroscopic properties. Values of thermodynamic and kinetic parameters for isoniazid binding to Mt-trHbN(III) and Mt-trHbN(II) are K= (1.1 ± 0.1)× 10(-4) M, k on= (5.3 ± 0.6)× 10(3) M(-1) s(-1) and k off= (4.6 ± 0.5)× 10(-1) s(-1); and D= (1.2 ± 0.2)× 10(-3) M, d on= (1.3 ± 0.4)× 10(3) M(-1) s(-1), and d off=1.5 ± 0.4 s(-1), respectively, at pH 7.0 and 20.0°C. Accordingly, isoniazid inhibits competitively azide binding to Mt-trHbN(III) and Mt-trHbN(III)-catalyzed peroxynitrite isomerization. Moreover, isoniazid inhibits Mt-trHbN(II) oxygenation and carbonylation. Although the structure of the Mt-trHbN-isoniazid complex is not available, here we show by docking simulation that isoniazid binding to the heme-Fe atom indeed may take place. These data suggest a direct role of isoniazid to impair fundamental functions of mycobacteria, e.g. scavenging of reactive nitrogen and oxygen species, and metabolism. |
| format |
article |
| author |
Paolo Ascenzi Andrea Coletta Yu Cao Viviana Trezza Loris Leboffe Gabriella Fanali Mauro Fasano Alessandra Pesce Chiara Ciaccio Stefano Marini Massimo Coletta |
| author_facet |
Paolo Ascenzi Andrea Coletta Yu Cao Viviana Trezza Loris Leboffe Gabriella Fanali Mauro Fasano Alessandra Pesce Chiara Ciaccio Stefano Marini Massimo Coletta |
| author_sort |
Paolo Ascenzi |
| title |
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| title_short |
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| title_full |
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| title_fullStr |
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| title_full_unstemmed |
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N. |
| title_sort |
isoniazid inhibits the heme-based reactivity of mycobacterium tuberculosis truncated hemoglobin n. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/d912f31bc02142dcb6a8c54aacb115a9 |
| work_keys_str_mv |
AT paoloascenzi isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT andreacoletta isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT yucao isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT vivianatrezza isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT lorisleboffe isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT gabriellafanali isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT maurofasano isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT alessandrapesce isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT chiaraciaccio isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT stefanomarini isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn AT massimocoletta isoniazidinhibitsthehemebasedreactivityofmycobacteriumtuberculosistruncatedhemoglobinn |
| _version_ |
1718421052964470784 |